{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:31:15Z","timestamp":1790875875320,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"BMBF Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymthe.2024.03.037","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T12:30:30Z","timestamp":1711801830000},"page":"1628-1642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia"],"prefix":"10.1016","volume":"32","author":[{"given":"Masoud","family":"Nasri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte U.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perihan","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dannenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Arreba-Tutusaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Borbaran-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Klimiankou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-2324","authenticated-orcid":false,"given":"Julia","family":"Skokowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.03.037_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2024.03.037_bib2","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood.V96.7.2317","article-title":"Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia","volume":"96","author":"Dale","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.037_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE-associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.2420009","article-title":"Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells","volume":"232","author":"Souza","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.03.037_bib5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2019-129844","article-title":"Response to High Dose G-CSF Treatment (20\u03bcg\/kg\/d or Higher) of Patients with Congenital Neutropenia: An Analysis By the Scnir in Europe","volume":"134","author":"Zeidler","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.037_bib6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","article-title":"Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"126","author":"Fioredda","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.037_bib7","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1200470109","article-title":"NSP4, an elastase-related protease in human neutrophils with arginine specificity","volume":"109","author":"Perera","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.03.037_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/humu.22308","article-title":"The Spectrum of ELANE Mutations and their Implications in Severe Congenital and Cyclic Neutropenia","volume":"34","author":"Germeshausen","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2024.03.037_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2005-11-4689","article-title":"Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response","volume":"108","author":"K\u00f6llner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.037_bib11","first-page":"4179","article-title":"Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis","volume":"110","author":"Grenda","year":"2007","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib12","first-page":"3539","article-title":"Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane","volume":"117","author":"Nanua","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13823","article-title":"ELANE mutant\u2013specific activation of different UPR pathways in congenital neutropenia","volume":"172","author":"Nustede","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3324\/haematol.2019.221804","article-title":"CRISPR\/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients","volume":"105","author":"Nasri","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.03.037_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2020.12.015","article-title":"Dissecting ELANE neutropenia pathogenicity by human HSC gene editing","volume":"28","author":"Rao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.03.037_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.03.037_bib67","author":"FDA"},{"key":"10.1016\/j.ymthe.2024.03.037_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2024.03.037_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nbt.3101","article-title":"Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases","volume":"33","author":"Frock","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib19","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gky222","article-title":"Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption","volume":"46","author":"Gopalappa","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.03.037_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.03.037_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","article-title":"Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects","volume":"11","author":"Shen","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2024.03.037_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-023-35886-6","article-title":"Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing","volume":"14","author":"Tao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.037_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1189\/jlb.71.5.821","article-title":"Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in\u00a0vitro","volume":"71","author":"Allport","year":"2002","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib24","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.4049\/jimmunol.172.7.4493","article-title":"Neutrophil elastase (NE)-deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in\u00a0vivo","volume":"172","author":"Young","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1165\/rcmb.2003-0253OC","article-title":"Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites","volume":"30","author":"Hirche","year":"2004","journal-title":"Am. J. Respir. Cel Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib26","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.4049\/jimmunol.173.12.7277","article-title":"Papillon-Lef\u00e8vre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C\/dipeptidyl peptidase I deficiency in humans","volume":"173","author":"Pham","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"Tsuchiya","year":"1980","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.03.037_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acschembio.7b00549","article-title":"CRISPR-mediated tagging of endogenous proteins with a luminescent peptide","volume":"13","author":"Schwinn","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.03.037_bib30","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1093\/nar\/gkw1069","article-title":"The eukaryotic promoter database in its 30th year: focus on non-vertebrate organisms","volume":"45","author":"Dreos","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.03.037_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/crispr.2020.0022","article-title":"Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data","volume":"4","author":"Bloh","year":"2021","journal-title":"Crispr J."},{"key":"10.1016\/j.ymthe.2024.03.037_bib32","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/s41467-019-12028-5","article-title":"CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation","volume":"10","author":"Tuladhar","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.037_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-1-0716-0290-4_26","article-title":"Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation","volume":"2115","author":"Mir","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.3583","article-title":"Analyzing CRISPR genome-editing experiments with CRISPResso","volume":"34","author":"Pinello","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","article-title":"Cas-analyzer: an online tool for assessing genome editing results using NGS data","volume":"33","author":"Park","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.03.037_bib36","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/scd.2015.0289","article-title":"Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain","volume":"25","author":"Coughlan","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ymthe.2024.03.037_bib38","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/bioinformatics\/btz867","article-title":"CRISPRitz: rapid, high-throughput and variant-aware in\u00a0silico off-target site identification for CRISPR genome editing","volume":"36","author":"Cancellieri","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.03.037_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41588-022-01257-y","article-title":"Human genetic diversity alters off-target outcomes of therapeutic gene editing","volume":"55","author":"Cancellieri","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.03.037_bib40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.03.037_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2023.1130736","article-title":"T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds","volume":"5","author":"Rhiel","year":"2023","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymthe.2024.03.037_bib42","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41467-021-22417-4","article-title":"CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data","volume":"12","author":"Amit","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.037_bib43","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.03.037_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm0598-615","article-title":"Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis","volume":"4","author":"Belaaouaj","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.03.037_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809958","article-title":"Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives","volume":"11","author":"Naldini","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.03.037_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2021.12.399","article-title":"Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applications","volume":"107","author":"Haltalli","year":"2022","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib48","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","article-title":"Frequent aneuploidy in primary human T\u00a0cells after CRISPR\u2013Cas9 cleavage","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.stem.2023.04.014","article-title":"Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy","volume":"30","author":"Ferrari","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.03.037_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.618378","article-title":"Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation","volume":"3","author":"Ferrari","year":"2021","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymthe.2024.03.037_bib51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.03.037_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.omtm.2023.06.003","article-title":"The p53 challenge of hematopoietic stem cell gene editing","volume":"30","author":"Dorset","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.03.037_bib53","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.ymthe.2020.08.004","article-title":"CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia","volume":"28","author":"Tran","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.037_bib54","series-title":"Graphite Bio Announces Voluntary Pause of Phase 1\/2 CEDAR Study of Nulabeglogene Autogedtemcel (Nula-Cel) for Sickle Cell Disease.[Press Release]","author":"Bio","year":"2023"},{"key":"10.1016\/j.ymthe.2024.03.037_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omtn.2019.05.025","article-title":"In\u00a0Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods","volume":"17","author":"Pattabhi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.03.037_bib56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.037_bib57","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib58","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib59","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ymthe.2021.09.001","article-title":"Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells","volume":"29","author":"Lee","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.037_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660302","article-title":"Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for Ex-Vivo Gene Editing","volume":"12","author":"Dudek","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.03.037_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.omtm.2022.06.002","article-title":"Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia","volume":"26","author":"Sabo","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.03.037_bib62","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.03.037_bib63","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2024.03.037_bib64","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/s41596-021-00626-x","article-title":"Defining genome-wide CRISPR\u2013Cas genome-editing nuclease activity with GUIDE-seq","volume":"16","author":"Malinin","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.03.037_bib65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624002156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624002156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:24:32Z","timestamp":1776803072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624002156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1525001624002156"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.037","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}